FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

712519008: Daclatasvir (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3082832019 Daclatasvir (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3082833012 Daclatasvir en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Daclatasvir (substance) Is a Hepatitis C virus protein NS5A inhibitor true Inferred relationship Some
Daclatasvir (substance) Has disposition (attribute) Hepatitis C virus protein NS5A inhibitor (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing daclatasvir (medicinal product) Has active ingredient True Daclatasvir (substance) Inferred relationship Some 1
Daclatasvir-containing product in oral dose form Has active ingredient True Daclatasvir (substance) Inferred relationship Some 1
Product containing only daclatasvir (medicinal product) Has active ingredient True Daclatasvir (substance) Inferred relationship Some 1
Product containing only daclatasvir in oral dose form (medicinal product form) Has active ingredient True Daclatasvir (substance) Inferred relationship Some 1
Daclatasvir dihydrochloride (substance) Is modification of (attribute) True Daclatasvir (substance) Inferred relationship Some
Product containing precisely daclatasvir (as daclatasvir dihydrochloride) 60 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Daclatasvir (substance) Inferred relationship Some 1
Product containing precisely daclatasvir (as daclatasvir dihydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Daclatasvir (substance) Inferred relationship Some 1
Product containing precisely daclatasvir (as daclatasvir dihydrochloride) 90 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Daclatasvir (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start